NCT00205725View on ClinicalTrials.gov

Pfizer/IVGTT/Ziprasidone/Olanzapine

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

SchizophreniaType 2 Diabetes Mellitus

Interventions

DRUG

Ziprasidone, Olanzapine

Trial Locations (1)

63110

Washington University School of Medicine, Psychiatry Dept., St Louis

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Washington University School of Medicine

OTHER